Makale
Tam Makale
Uluslararası
2019
Hepatitis C Prevalence in Hemodialysis Patients and the Results of New Antiviral Therapy
TURKISH JOURNAL OF NEPHROLOGY
Cilt 28 · Sayı 2 · ss. 103–108 · 01.04.2019
Özet
Objective: Hepatitis C virus (HCV) is more common in patients undergoing dialysis compared to the normal population. The objective of this study was to investigate the incidence of hepatitis C in patients undergoing hemodialysis and to share the results of the antiviral drugs used in the treatment of our patients with HCV.
Anahtar kelimeler
PREVALENCE
Hemodialysis
HEPATITIS-C
antiviral treatment
Sürdürülebilir Kalkınma Amaçları
-
SKA 3: Sağlıklı Bireyler
Atıf için künye
ÇELİK, N., ÇELİK, O., Sevinç, C., & ÜNAL, O. (2019). Hepatitis C Prevalence in Hemodialysis Patients and the Results of New Antiviral Therapy. TURKISH JOURNAL OF NEPHROLOGY, 28(2), 103–108. https://doi.org/10.5152/turkjnephrol.2019.3311
BibTeX
@article{celik2019-243668,
author = {ÇELİK, NESLİHAN and ÇELİK, ONUR and Sevinç, Can and ÜNAL, ONUR},
title = {Hepatitis C Prevalence in Hemodialysis Patients and the Results of New Antiviral Therapy},
journal = {TURKISH JOURNAL OF NEPHROLOGY},
year = {2019},
volume = {28},
number = {2},
pages = {103--108},
issn = {2667-4440},
doi = {10.5152/turkjnephrol.2019.3311},
url = {https://akademik.atauni.edu.tr/yayinlar/243668-hepatitis-c-prevalence-in-hemodialysis-patients-and-the-results-of-new-antiviral}
}